Product
CsA+ATG+Herombopag
1 clinical trial
3 indications
Indication
Aplastic AnemiaIndication
Childhood absence epilepsyIndication
Drug TherapyClinical trial
Establishment of an Efficacy and Relapse Prediction System for Immunosuppressants Combined With Thrombopoietin Receptor Agonists in the Treatment of Aplastic AnemiaStatus: Recruiting, Estimated PCD: 2025-01-30